Anti-ICOS-L / ICOS Ligand / B7RP-1 (Immuno-Oncology Target) Monoclonal Antibody(Clone: ICOSL/3111), Clone: [ICOSL/3111], Mouse

Artikelnummer: ABI-36-2303-20
Artikelname: Anti-ICOS-L / ICOS Ligand / B7RP-1 (Immuno-Oncology Target) Monoclonal Antibody(Clone: ICOSL/3111), Clone: [ICOSL/3111], Mouse
Artikelnummer: ABI-36-2303-20
Hersteller Artikelnummer: 36-2303-20
Alternativnummer: ABI-36-2303-20-20UG
Hersteller: Abeomics
Wirt: Mouse
Kategorie: Antikörper
Applikation: ELISA, FACS, IF, IHC
Spezies Reaktivität: Human
Immunogen: Recombinant fragment of human ICOSLG (B7RP-1) protein (around aa 23-149) (exact sequence is proprietary)
Alternative Synonym: B7 homolog 2 (B7H2), B7 like protein Gl50, B7 related protein 1 (B7RP1), CD275, CD275 antigen, GL50, ICOS LG, ICOS ligand (ICOSL), Inducible T cell co stimulator ligand, LICOS, Transmembrane protein B7 H2 ICOS ligand
This MAb recognizes a protein of 36kDa, identified as ICOS-L. It is a ligand for the ICOS receptor that initiates T and B cell proliferation and cytokine secretion. ICOS-L interactions play an essential role in T cell-dependent B cell activation in peripheral lymphoid organs such as spleen and lymph nodes. ICOS-L protein is present in myeloid leukocytes, and by Northern blot there are 2.4, 3.0, and 7.0 kb transcripts in brain, heart, kidney, and liver, with lower expression in colon and thymus, and a 1.1 kb transcript in leukocytes. Tumor necrosis factor alpha (TNF), granulocyte-macrophage colony-stimulating factor (GM-CSF) and interleukin-4 (IL-4) enhance its expression. LPS-induced up-regulation of ICOS-L is dependent on the MyD88-dependent signaling pathway.
Klonalität: Monoclonal
Klon-Bezeichnung: [ICOSL/3111]
NCBI: 23308
UniProt: O75144
Application Verdünnung: ELISA (For coating, order antibody without BSA), Flow Cytometry (1-2ug/million cells), ,Immunofluorescence (1-2ug/ml),,Immunohistochemistry (Formalin-fixed) (1-2ug/ml for 30 min at RT),(Staining of formalin-fixed tissues requires heating tissue sections i